BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rahat MA. Targeting Angiogenesis With Peptide Vaccines. Front Immunol 2019;10:1924. [PMID: 31440262 DOI: 10.3389/fimmu.2019.01924] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi W, Qiu Q, Feng Z, Tong Z, Guo W, Zou F, Yue N, Huang W, Qian H. Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy. J Immunother Cancer 2021;9:e002523. [PMID: 34083420 DOI: 10.1136/jitc-2021-002523] [Reference Citation Analysis]
2 Goedegebuure RSA, Wentink MQ, van der Vliet HJ, Timmerman P, Griffioen AW, de Gruijl TD, Verheul HMW. A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid Malignancies. Oncologist 2021;26:e218-29. [PMID: 33105058 DOI: 10.1002/onco.13576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Claire A, Lethier L, Guillaume YC. An organic monolithic capillary column functionalized with human serum albumin and its application for the nano – chromatography study of its binding with universal cancer peptides and its impact on immunogenicity. Journal of Liquid Chromatography & Related Technologies 2020;43:777-83. [DOI: 10.1080/10826076.2020.1811727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Abdelmoneim AH, Mustafa MI, Abdelmageed MI, Murshed NS, Dawoud ED, Ahmed EM, Kamal Eldein RM, Elfadol NM, Sati AOM, Makhawi AM. Immunoinformatics design of multiepitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a target. Immunol Med 2021;44:35-52. [PMID: 32692610 DOI: 10.1080/25785826.2020.1794165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Kondo S, Shimizu T, Koyama T, Sato J, Iwasa S, Yonemori K, Fujiwara Y, Shimomura A, Kitano S, Tamura K, Yamamoto N. First-in-human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors. Cancer Sci 2021;112:1514-23. [PMID: 33615628 DOI: 10.1111/cas.14765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang B, Chen S, Zheng Q, Liu Y, Shi G. Peptide-Based Vaccination Therapy for Rheumatic Diseases. J Immunol Res 2020;2020:8060375. [PMID: 32258176 DOI: 10.1155/2020/8060375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zahedipour F, Zamani P, Jamialahmadi K, Jaafari MR, Sahebkar A. Vaccines targeting angiogenesis in melanoma. Eur J Pharmacol 2021;912:174565. [PMID: 34656608 DOI: 10.1016/j.ejphar.2021.174565] [Reference Citation Analysis]
8 Chelliah SS, Paul EAL, Kamarudin MNA, Parhar I. Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas. Molecules 2021;26:1169. [PMID: 33671796 DOI: 10.3390/molecules26041169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Jiang Y, Zhou J, Zou D, Hou D, Zhang H, Zhao J, Li L, Hu J, Zhang Y, Jing Z. Overexpression of Limb-Bud and Heart (LBH) promotes angiogenesis in human glioma via VEGFA-mediated ERK signalling under hypoxia. EBioMedicine 2019;48:36-48. [PMID: 31631037 DOI: 10.1016/j.ebiom.2019.09.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]